← Open Payments lookup

SARAH ZIELINSKI: Open Payments

NPI 1912574120 · OKEMOS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,134 in 49 payments from 19 companies in 2025. Trend: 2023 $743 · 2024 $1,475 · 2025 $1,134

Food & beverage: $1,135
CompanyPaymentsAmount
ABBVIE INC.12$264
Lilly USA, LLC5$161
Octapharma USA, Inc.1$125
Novo Nordisk Inc5$104
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$78
Bayer Healthcare Pharmaceuticals Inc.3$51
Boehringer Ingelheim Pharmaceuticals, Inc.2$46
Otsuka America Pharmaceutical, Inc.2$45
PFIZER INC.2$37
AstraZeneca Pharmaceuticals LP2$31

Products named: QULIPTA, FIBRYGA, ZEPBOUND, VRAYLAR, CAPLYTA, REXULTI, Ozempic, Kerendia.

Industry payments across MI — which companies pay providers there.